Janus Henderson Group’s Emergent Biosolutions EBS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-20,359	Closed	-$69.3K	–	2567
2023 Q3	$69.3K	Buy	20,359 +55	+0.3%	+$305	﹤0.01%	2543
2023 Q2	$149K	Sell	20,304 -44	-0.2%	-$408	﹤0.01%	2518
2023 Q1	$211K	Sell	20,348 -47,024	-70%	-$568K	﹤0.01%	2470
2022 Q4	$796K	Sell	67,372 -77,094	-53%	-$1.19M	﹤0.01%	1485
2022 Q3	$3.03M	Buy	144,466 +71,367	+98%	+$1.99M	﹤0.01%	1145
2022 Q2	$2.27M	Sell	73,099 -720,233	-91%	-$24.6M	﹤0.01%	1006
2022 Q1	$32.6M	Sell	793,332 -1,029,549	-56%	-$45.4M	0.02%	622
2021 Q4	$79.2M	Sell	1,822,881 -1,047,022	-36%	-$47.4M	0.03%	414
2021 Q3	$144M	Sell	2,869,903 -779,066	-21%	-$47.2M	0.06%	289
2021 Q2	$230M	Buy	3,648,969 +889,033	+32%	+$57.1M	0.1%	212
2021 Q1	$256M	Buy	2,759,936 +1,815,872	+192%	+$186M	0.12%	191
2020 Q4	$84.6M	Buy	+944,064	New	+$86.6M	0.04%	406
2018 Q2	–	Sell	-4,051	Closed	-$213K	–	1403
2018 Q1	$213K	Buy	+4,051	New	+$202K	﹤0.01%	1337